Snapshot img

Medical Devices Market Size 2025-2029

The medical devices market size is valued to increase by USD 223 billion, at a CAGR of 6.5% from 2024 to 2029. Increasing prevalence of diseases will drive the medical devices market.

Major Market Trends & Insights

North America dominated the market and accounted for a 37% growth during the forecast period.
By End-user - Hospitals and ASCs segment was valued at USD 380.90 billion in 2023
By Product Type - Diagnostic devices segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 64.11 billion
Market Future Opportunities: USD 223.00 billion
CAGR : 6.5%
North America: Largest market in 2023

Market Summary

The market encompasses a dynamic and evolving landscape, driven by the increasing prevalence of diseases and the emergence of innovative medical technologies. Core technologies, such as robotics, artificial intelligence, and nanotechnology, are revolutionizing healthcare delivery, while applications span from diagnostics and monitoring to therapy and surgery. Service types and product categories, including medical implants, diagnostic equipment, and therapeutic devices, continue to expand, driven by advancements in materials science and biotechnology. Regulatory bodies play a crucial role in shaping market dynamics, with stringent regulations ensuring safety and efficacy.
For instance, the US Food and Drug Administration (FDA) approved over 4,000 medical devices in 2020 alone. Despite these opportunities, challenges persist, including declining reimbursement and cost containment measures, which impact market growth. Overall, the market demonstrates a robust and continually evolving ecosystem, offering significant potential for innovation and growth.

What will be the Size of the Medical Devices Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Medical Devices Market Segmented and what are the key trends of market segmentation?

The medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and ASCs
  Clinics
  Others


Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascular
  Orthopedic
  Diagnostic imaging
  Dental
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By End-user Insights

The hospitals and ascs segment is estimated to witness significant growth during the forecast period.

The market encompasses a diverse range of technologies and applications, with hospitals and Ambulatory Surgical Centers (ASCs) representing a significant and growing sector. Hospitals and ASCs are essential consumers of medical devices, requiring equipment for diagnosis, treatment, and patient monitoring. The market's expansion is fueled by increasing healthcare expenditures from both public and private entities. Approximately 45% of global medical device sales stem from hospitals and ASCs, with this figure projected to reach 48% by 2026. Simultaneously, the market's overall value is anticipated to surge by 12% in the next five years, reaching a total worth of USD675 billion.

Sensor technology, including wearable sensors, plays a pivotal role in this market, enabling remote patient monitoring and minimally invasive procedures. Quality control systems, diagnostic imaging, and medical implants, such as prosthetic limbs, are other key areas of growth. Advanced technologies like artificial intelligence, data analytics, and data encryption are revolutionizing medical devices, enhancing their capabilities and improving patient outcomes. Minimally invasive surgery, risk management, supply chain management, design controls, and patient monitoring are some of the market trends shaping the industry. Signal processing, clinical trials, device sterilization, electrical stimulation, surgical instruments, tissue engineering, regulatory compliance, material science, biocompatible materials, wireless communication, software validation, therapeutic devices, human factors engineering, machine learning, manufacturing processes, drug delivery systems, image processing, and additive manufacturing are all integral components of the market.

In summary, the market is a dynamic and evolving sector, driven by advancements in technology and increasing demand from hospitals and ASCs. With a projected growth of 12% and a total value of USD675 billion by 2026, this market offers significant opportunities for innovation and expansion.

This statistic depicts the projected percentage of global medical device revenue attributed to select major countries as of 2018. As of that year, some ** percent of medical device sales worldwide will occur in the United States.

BCC Research Market Analyst says global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a CAGR of 9.8%.

Between 2007 and 2021, the revenue generated by the medical devices industry worldwide boomed. In 2007 the sales of medical devices generated revenue of *** billion euros, while by 2021 this figure reached *** billion euros. Revenue from medical devices was forecast to grow even further in the following years, reaching *** billion euros by 2024.

The global sales of homecare medical devices are estimated to be worth USD 172.6 billion in 2025 and are anticipated to reach a value of USD 403.4 billion by 2035.

Attributes	Key Insights
Historical Size, 2024	USD 158.5 billion
Estimated Size, 2025	USD 172.6 billion
Projected Size, 2035	USD 403.4 billion
Value-based CAGR (2025 to 2035)	8.9%

Semi Annual Market Update

Particular	Value CAGR
H1	9.6% (2024 to 2034)
H2	9.3% (2024 to 2034)
H1	8.9% (2025 to 2035)
H2	8.4% (2025 to 2035)

Country-wise Insights

Country	Value CAGR (2025 to 2035)
United States	2.3%
Germany	2.0%
Italy	2.5%
UK	4.6%
India	7.3%
China	6.8%

Category-wise Insights

Product	Value Share (2025)
Wheelchairs	57.4%

By Distribution Channel	Value Share (2025)
Online Retailers	39.5%

Medical Device Connectivity Market was valued at USD 2.49 Billion in 2024 and is projected to reach USD 13.4 Billion by 2032, growing at a CAGR of 23.40% from 2026 to 2032.Increasing Adoption of Electronic Health Records (EHR): The widespread and growing adoption of Electronic Health Records (EHRs) is a primary catalyst for the medical device connectivity market. As healthcare systems globally transition from paper based to digital records, the need for seamless, automated data flow from patient facing medical devices directly into EHRs has become critical. This shift is driven by the demand for improved clinical efficiency, reduced data entry errors, and enhanced patient safety. Data from sources like the Office of the National Coordinator for Health Information Technology (ONC) and the World Health Organization (WHO) confirm this trend, with EHR adoption in U.S. hospitals nearing 96% and 60% of WHO member countries having adopted national EHR systems by 2023.

The top medical technology companies globally include big name companies such as General Electric, Philips, and Medtronic. As of 2021, the leading medical technology company based on market share was Medtronic (U.S.). At that time, Medtronic held *** percent of the overall medical technology market. The company’s hold on medical technology is projected to increase slightly to *** percent by 2024. Medical technology industry The global medical technology industry includes different types of technology that are broadly categorized as medical devices, in vitro diagnostics and digital health solutions. The total medical technology revenue has been increasing in recent years and is expected to increase dramatically by the year 2024. Research and development in the industry is also gaining ground and has experienced some of the largest growth in spending from 2015 to 2016, with significant growth expected in the future. Company spotlight: Medtronic Among the various medical technology companies, Medtronic is among the top in many measures. Medtronic produces medical products and devices for cardiac and vascular disease, minimally invasive therapies, restorative therapies and diabetes. In 2017, Medtronic was the top medical technology company among those that produce cardiac devices. The company beat out other competitors such as Abbott and Boston Scientific by a significant percentage of the market share. Medtronic’s total revenue worldwide has been increasing significantly in recent years and in the company’s fiscal year 2022 had reached an all time high.

The Report Covers Global Smart Medical Devices Market Size & Trends and It is Segmented by Product Type (Diagnostic and Monitoring and Therapeutic Devices), End User (Hospitals/Clinics, Home-Care Setting, and More), by Connectivity (Bluetooth, Wi-Fi, and More), by Distribution Channel (Offline and Online), and Geography. The Market Provides the Value (in USD Million) for the Above Segments.

According to Cognitive Market Research, the global medical device technologies market size will be USD 489241.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2025 to 2033.

North America held the major market share for more than 40% of the global revenue with a market size of USD 181019.36 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 141880.04 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 117417.96 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 18591.18 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2033.
Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 19569.66 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 10763.31 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033.
Orthopedic devices category is the fastest growing segment of the medical device technologies industry

Market Dynamics of Medical Device Technologies Market

Key Drivers for Medical Device Technologies Market

Continuous Innovation in Medical Device Technologies to Boost Market Growth

The medical device technologies market is experiencing significant growth, driven by continuous innovation across various segments, including diagnostic, therapeutic, and surgical devices. Advancements in minimally invasive technologies, wearable medical devices, and digital health solutions are key drivers in improving patient outcomes and operational efficiency. The integration of artificial intelligence (AI), 3D printing, and robotic-assisted surgery enhances precision and personalized care. Additionally, increasing healthcare demands, an ageing population, and rising chronic diseases propel the need for cutting-edge solutions. Regulatory support, along with rising investment in R&D, fosters continuous technological evolution, leading to better and more accessible healthcare. In January 2024, GE Healthcare agreed to acquire MIM Software, one of the leading providers of medical imaging analysis and AI solutions. The company specializes in areas such as radiation oncology, molecular radiotherapy, diagnostic imaging, and urology in various healthcare settings.

https://investor.gehealthcare.com/news-releases/news-release-details/ge-healthcare-announces-agreement-acquire-mim-software

Rising Shift toward Wearable Devices to Boost Market Growth

The medical device technologies market is experiencing significant growth, driven by a rising shift toward wearable devices. Wearable medical devices, such as smartwatches, fitness trackers, and health-monitoring gadgets, are gaining popularity due to their ability to offer continuous, real-time health data collection. Consumers increasingly demand personalized healthcare, and these devices provide an efficient way to monitor vital signs, manage chronic conditions, and track overall wellness. Technological advancements in sensors, connectivity (e.g., Bluetooth), and data analytics further enhance the functionality of wearable devices, fueling the market's growth and improving patient outcomes through better management and early detection of health issues.

Restraint Factor for the Medical Device Technologies Market

High Costs Associated with the Devices Will Limit Market Growth

The medical device technologies market faces a significant restraint due to the high costs associated with the devices. Advanced medical devices, such as diagnostic equipment, surgical instruments, and implantable devices, often require substantial investment in research, development, and regulatory compliance. The high manufacturing costs are passed on to consumers, making these technologies less affordable, especially in emerging markets. Additionally, the cost of maintaining and updating these devices, along with the need for specialized training, further compounds the financial burden for healthcare providers, limiting market adoption...

This statistic represents the projected market size of the U.S. medical device industry in 2015 and 2017. It is expected that by 2017, U.S. medical device companies will amount around *** billion U.S. dollars.

Size of the U.S. medical device industry

In 2014, the United States was the largest target market for medical devices, with an estimated global market share of around ** percent. In light of citizens’ increased access to health insurance, this industry is projected to grow at an annual rate of *** percent from 2012 through 2017. The most important company within the U.S. medical device industry remains Johnson & Johnson. The New Jersey company is not only known for its medical device and diagnostics products, but also for its pharmaceuticals and consumer products. Johnson & Johnson generated about **** billion U.S. dollars in revenue globally - with just under ** billion U.S. dollars originating from sales to customers in the United States in 2014. That year, the company raked in around **** billion U.S. dollars in revenue from its medical devices and diagnostics segment, the majority of which was derived from orthopedic device sales.

Johnson & Johnson also invests heavily in research and development, having spent almost *** billion U.S. dollars in 2014. Of the company’s total R&D expenditures, some *** percent went to the medical devices and diagnostics segment.

Medical Device Training Services Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period from 2024–2031.

Global Medical Device Training Services Market Drivers

The market for medical device training services is influenced by several drivers, including:

Technological Advancements: Rapid advancements in medical technology lead to the introduction of new medical devices. As these devices become increasingly complex, the need for comprehensive training becomes crucial. Regulatory Compliance: Healthcare regulations often require proper training on the usage of medical devices to ensure compliance with safety and effectiveness standards. Organizations must ensure their staff is trained to meet regulatory requirements, driving demand for training services. Growing Healthcare Sector: The expansion of the healthcare sector, including hospitals, clinics, and outpatient facilities, increases the need for medical device training services as new facilities and personnel are onboarded.

Global Medical Device Training Services Market Restraints

The Medical Device Training Services Market, like any sector, faces several market restraints that can impact its growth and sustainability. Here are some key restraints to consider:

Regulatory Challenges: Medical devices are subject to stringent regulations by agencies like the FDA in the U.S. or the EMA in Europe. Compliance with these regulations can be complex and costly, potentially hindering the market's growth. High Costs of Training Programs: Setting up and maintaining training programs can be expensive. Companies may hesitate to invest in extensive training, especially smaller organizations with limited budgets. Technological Advancements: Rapid technological advancements in medical devices can make training programs quickly outdated. This requires continuous updates and adaptations in training materials and methods, which can strain resources.

According to Future Market Insights research, during the projected period, the global medical device analytical testing outsourcing market is expected to expand at a CAGR of 6.4%. The industry value is projected to increase from USD 5,844 million in 2024 to USD 10,867.3 million by 2034. The industry was valued at USD 5,492.40 million at the end of 2023.

Attributes	Key Insights
Historical Size, 2023	USD 5,492.40 million
Estimated Size, 2024	USD 5,844 million
Projected Size, 2034	USD 10,867.3 million
Value-based CAGR (2024 to 2034)	6.4%

Semi Annual Market Update

Particulars	Value CAGR
H1	7.4% (2023 to 2033)
H2	7.1% (2023 to 2033)
H1	6.4% (2024 to 2034)
H2	5.9% (2024 to 2034)

Country-wise Insights

Countries	Value CAGR (2024 to 2034)
India	8.8%
Spain	4.3%
The United States	3.6%
Canada	3.8%

Category-wise Insights

Service	Extractable and Leachable (E&L) Testing
Value Share (2024)	26.15%

End Use	Medical Device Analytical Testing Outsourcing
Value Share (2024)	81.5%

Major companies have continued to dominate medical device manufacturing, making strategic acquisitions and heavily investing in research and development (R&D) to boost market share. Industry giants like Johnson & Johnson and Boston Scientific have actively pursued acquisitions to expand their portfolios and strengthen their market positions. Johnson & Johnson's 2022 acquisition of Abiomed fortified its place in treating cardiovascular diseases, and Boston Scientific's 2023 acquisition of Axionics expanded its urology product offerings. At the same time, high demand for healthcare from the aging population has made room for an influx of start-ups. Revenue has been climbing at a CAGR of 1.2% to an estimated $56.4 billion over the five years through 2025, including an expected lift of 3.1% in 2024 alone. Innovation has remained a pivotal element in securing growth for medical device manufacturers. Advances in technology and research have led to the development of sophisticated products that can treat rare chronic conditions and ailments. New smart implantable devices, like Biotronik's Dynagen A3 cardiac defibrillator, enhance physicians' ability to treat patients. Government support has been a solid boon for manufacturers, with initiatives like revamped R&D tax credits fuelling innovation. Medical device manufacturers are increasingly focusing on personalizing products and integrating AI, as seen with Medtronic's Genius GI endoscopy tool, allowing them to cater to specific patient needs and improve healthcare outcomes. Since healthcare professionals are under pressure to use the best tools available, the release of new innovative products has directly spurred sales and pushed revenue upward. Buyers' reliance on effective medical devices gives manufacturers significant control over prices, allowing them to maintain solid profit despite swelling R&D budgets. Demographic changes and technological advancements will continue enabling medical device manufacturers to drive revenue growth. As the median age of the U.S. population climbs, demand for orthopedic and neurological devices will surge. Companies will continue investing heavily in R&D to outpace competition in domestic and international markets. Upcoming regulatory changes and potential tariffs under the second Trump administration could present opportunities and challenges, easing regulations but deterring international trade. Despite these hurdles, revenue is set to outpace the previous period's growth, surging at a CAGR of 2.6% to an estimated $64.3 billion through the end of 2030.

In Medical Devices Market, Robotic surgeries have gained momentum in recent years, with multiple new device launches and approvals.

• The industry was valued at US$ 27.6 Bn in 2022
• It is estimated to grow at a CAGR of 6.3% from 2023 to 2031 and reach US$ 47.4 Bn by the end of 2031

Pediatric Medical Devices Market Snapshot

Attribute	Detail
Market Size in 2022	US$ 27.6 Bn
Market Forecast (Value) in 2031	US$ 47.4 Bn
Growth Rate (CAGR)	6.3%
Forecast Period	2023-2031
Historical Data Available for	2017-2021
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape	Market share analysis by company (2022) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Product In Vitro Diagnostic (IVD) Devices Cardiology Devices Diagnostic Imaging Devices Anesthesia & Respiratory Care Devices Neonatal ICU Devices Monitoring Devices Telemedicine Home-use Medical Devices End-user Hospitals Diagnostic Laboratories Ambulatory Surgical Centers Others
Regions Covered	North America Latin America Europe Asia Pacific Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Spain Italy Russia and CIS Japan China India ASEAN Brazil Mexico GCC South Africa
Companies Profiled	Abbott Boston Scientific Corporation Baxter International, Inc. Medtronic Cardinal Health, Inc. F. Hoffmann-La Roche Ltd. GE Healthcare Johnson & Johnson Siemens Healthinners Koninklikje Philips N.V. Stryker Corporation
Customization Scope	Available upon request
Pricing	Available upon request

Gain insights into the growth determinants, challenges, and opportunities in the Medical Device Connectivity Market with our comprehensive research report

The global implantable medical devices market size reached USD 141.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 209.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of chronic diseases, increasing demand for smaller, more advanced implantable medical devices, and growing integration of digital health technologies and connectivity features in implantable devices are some of the key factors driving the growth of the market.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 141.3 Billion
Market Forecast in 2033	USD 209.1 Billion
Market Growth Rate 2025-2033	4.5%

IMARC Group provides an analysis of the key trends in each segment of the global implantable medical devices market report, along with forecasts at the global and regional levels from 2025-2033. Our report has categorized the market based on product type, material and end-user.

The Single-Use Medical Device Reprocessing Market Report is Segmented by Product Type (Cardiovascular Catheters, Electrophysiology Catheters, and More), Service Provider (Third-party/Commercial Reprocessors, In-house/Hospital Reprocessing Units), Application (Cardiology, and More), End User (Hospitals & Surgical Centers, and More), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

The Global Medical Devices Outsourcing market is expanding at a healthy growth rate of 13% due to the increasing tendency of OEMs to outsource various stages of production and development. The market is further driven by the growing demand for cost-effective and high-quality medical devices, coupled with the rising prevalence of chronic diseases. Additionally, the […]

The global medical device coating market is estimated to grow from $8.2 billion in 2024 to $18.7 billion in 2035, growing at a compounded annual growth rate (CAGR) of 7.7% during the forecast period, till 2035